Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kit Pogliano
University of California, San Diego, Department: Miscellaneous
Should you be removed from our database? Contact us at [email protected]. Read more below.
Linnaeus
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Pogliano holds (b)(4) equity interest (jointly with his spouse) in Linnaeus as a co-founder. In addition, he receives income ((b)(4)) from the company for consulting on bacterial cell biology and physiology. The mission of the company is the discovery, development and commercialization of innovative technologies that accelerate drug discovery, and they licensed Bacterial Cytological Profiling (BCP) platform technology discovered and developed in Dr. Pogliano's lab. This project is to use BCP and Target Direct Genome Mining (TDGM) together in a combined platform to screen a diverse collection of cave bacteria for novel molecules that are active against multidrug resistant bacteria, which will allow the discover of new antibiotics to combat drug resistant bacterial pathogens.
New Genetic Tools for Accessing Anti-Infective Agents from Gram-Negative Bacteria
Project Narrative In this proposal I describe a plan to build genetic tools for cloning, heterologous expression, and manipulation of the biosynthetic pathways responsible for producing didemnin and thalassospiramide, potent antiviral and immunosuppressive peptides, respectively. New analogues will be tested for antimicrobial activity and mechanism of action studies. Ultimately, the tools developed through this project will aid in future efforts to access untapped anti-infective agents from bacteria and develop them as drugs.
Filed on January 16, 2018.
Tell us what you know about Kit Pogliano's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Kit Pogliano”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kit Pogliano | University of California, San Diego | Conflict of Interest | Linnaeus Bioscience, | Value cannot be readily determined |
| Kit Pogliano | University of California, San Diego | Conflict of Interest | Linnaeus | $20,000 - $39,999 |
| Kit Pogliano | University of California, San Diego | Conflict of Interest | Linnaeus Bioscience, | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.